Jobs
-
Perrigo announced that it has settled a lawsuit filed by Endo Pharmaceuticals in May 2019 that alleged infringement of patents related to Nascobal cyanocobalamin nasal spray which expire in 2024. The terms of the settlement… Read more . . .
-
Third Pole Therapeutics said that it has received two new patents from the US Patent and Trademark Office covering its inhaled nitric oxide (iNO) delivery systems through at least 2038. The patents (No. 10,286,176 and… Read more . . .
-
Inhaler monitoring company Adherium said that it has signed a deal with Summatix (formerly Charm Informatics) to allow data from Adherium’s Hailie connected inhaler sensors to be accessed through the Summatix medical data platform. Adherium… Read more . . .
-
The United States Patent and Trademark Office has granted US patent No. 10376465 (“Monovalent Metal Cation Dry Powders for Inhalation”) to Pulmatrix, the company said. The claims cover formulations of Pulmazole inhaled dry powder itraconazole,… Read more . . .
-
Circassia Pharmaceuticals has announced the appointment of Jonathan Emms as Chief Operating Officer and as an Executive Director of the Board of Directors. Emms previously served in a number of executive roles at Pfizer, most… Read more . . .
-
Proveris Scientific has announced an expansion of its Americas and Asia Pacific customer service support team with the hire of Doug Mann as a Field Service Engineer. The company also recently added Stephen McDonald to… Read more . . .
-
According to generic inhalation device developer Merxin, the FDA has reviewed data for the company’s MRX001 blister multidose DPI and suggested that the agency would accept the MRX001 as an AB rated substitutable version of… Read more . . .
-
Evoke Pharma said that it has received minutes from a July 25, 2019 Type A meeting with the FDA and that the company now plans to resubmit its NDA for Gimoti metoclopramide nasal spray for… Read more . . .
-
Device developer and manufacturer Nemera has announced its acquisition of Insight Product Development, which will become the US office of Nemera’s “Insight Innovation Center.” The company’s other design center office is located in La Verpillière,… Read more . . .
-
AZTherapies has announced that former Dooner Laboratories and Muro Pharmaceuticals CEO George D. Behrakis has joined the company’s board of directors. Behrakis sold Dooner Laboratories, which manufactured theophylline products for asthma, to Rorer in 1977… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland